139 results
Page 3 of 7
6-K
EX-99
8n6 4urz5
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
POS AM
o8gq2n
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
zcea b5mnjr16
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B3
3je4uo6
2 Jul 20
Prospectus supplement
4:28pm
F-1
n8ywhss
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
1sri v4lkm
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
bn2xefl je
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
iq9 95dmx48y
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-3
of4jye6b1 9v0vn23bl
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
oi28l4kd8qpgr0lp0ox
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-1
69z gxwp7o189a2canqh
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
ijvumawi1d gbstot
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
424B5
re3n95
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
rhbi7p p6ig1mso
4 Feb 19
Prospectus supplement for primary offering
5:52pm
F-3
fw14idcl
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-99
ggy18 03jb
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
sbj kv3hf2g0oew0j
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am